Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Licenses Callida Genomics DNA Chip Patents

NEW YORK, May 20-Agilent Technologies has signed a licensing agreement for access to Callida Genomics' portfolio of non-universal DNA microarray patents, the two companies said today.


Through the agreement, Agilent will have access to intellectual property protected by a set of patents on the work of Callida CSO Radoje Drmanac, who was involved in early microarray development.


Callida will receive both up-front fees and potential running royalties. The license is non-exclusive.


Callida Genomics, a majority owned subisidiary of Hyseq Pharmaceuticals, was launched last fall following the settlement of a major patent lawsuit between Affymetrix and Hyseq. Researchers at Callida are working to commercialize the sequencing-by-hybridization technology that Drmanac developed.


For more information about this agreement, click here.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.